Ritalinic acid is an inactive major metabolite of the psychostimulant drug methylphenidate. When administered orally methylphenidate is extensively metabolized in the liver by hydrolysis of the ester group yielding ritalinic […]
List of articles in "Drug" category - Page 4
44′-Dimethylaminorex (44′-DMAR) is a centrally acting sympathomimetic drug related to 4-methylaminorex and pemoline. It was first detected in the Netherlands in December 2012 and has been sold as a designer […]
JNJ-26489112 is an anticonvulsant drug being developed by Johnson & Johnson for the treatment of epilepsy. JNJ-26489112 was designed as a successor to topiramate. It is expected to have fewer […]
Enramycin or Enduracidin is a polypeptide antibiotic produced by Streptomyces fungicidus. Enramycin is widely used as a feed additive for pigs and chickens to prevent necrotic enteritis induced by Gram-positive […]
Brincidofovir (CMX001) is an experimental antiviral drug being developed by Chimerix for the treatment of cytomegalovirus. It also has activity against adenoviruses BK virus and herpes simplex viruses.Brincidofovir is a […]
Metreleptin (Myalept) is a synthetic analog of the hormone leptin used to treat diabetes and various forms of dyslipidemia.
25P-NBOMe (2C-P-NBOMe NBOMe-2C-P) is a derivative of the phenethylamine 2C-P. It acts in a similar manner to related compounds such as 25I-NBOMe which are potent agonists at the 5HT2A receptor. […]
25E-NBOMe (2C-E-NBOMe NBOMe-2C-E) is a derivative of the phenethylamine 2C-E. It acts in a similar manner to related compounds such as 25I-NBOMe which are potent agonists at the 5HT2A receptor. […]
Sonidegib (INN) or erismodegib (USAN) also known as LDE225 is a Hedgehog signaling pathway inhibitor (via smoothened antagonism) being developed as an anticancer agent by Novartis.
PankoMab is a humanized monoclonal antibody recognizing the tumor-specific epitope of mucin-1 (TA-MUC1) enabling it to differentiate between tumor MUC1 and non-tumor MUC1 epitopes. PankoMab is being developed by Glycotope […]